Electrophysiology Mapping and Ablation Devices: A Global Strategic Business Report
San Jose, California (PRWEB) April 10, 2012
Follow us on LinkedIn Arrhythmias represent a challenging disorder that requires the use of electrophysiology technologies for locating and treating problem areas within a heart, that cause aberrations to the heart’s electrical conductivity. Arrhythmias are known to lead to serious conditions of heart, such as stroke or heart failure. Electrophysiology technologies emerged as a promising means to the treatment of these conditions that have been plagued with huge unmet needs from pharmacotherapies, the first line treatment option for arrhythmias. Electrophysiology also represents a less-invasive option for the treatment of arrhythmias. Electrophysiology ablation therapy addresses several types of arrhythmia, mainly atrial fibrillation, Premature Ventricular Contractions (PVC), atrial flutter, AV re-entrant tachycardia, and AV nodal tachycardia.
Driving factors for ablation therapies include aging baby-boomer population, huge unmet needs in pharmacological therapies, and advancement of technologies in ablation therapy. Aging population is driving the demand for minimally-invasive surgeries, such as ablation procedures, as against open-heart procedures. In addition, new modalities are increasing options for clinicians, thereby expanding the portfolio of services offered by clinicians. Conventionally, electrophysiology technologies have been mainly used in less complex procedures, such as Atrioventricular Nodal Reentrant Tachycardia. Going forwards, the demand for these technologies is expected to be driven by the increasing use of electrophysiology (EP) devices in complex procedures, such as Atrial fibrillation, which represents the most prevalent form of arrhythmia. Against the backdrop of rising number of electrophysiology procedures globally, clinicians continue to demand for advanced, intuitive tools that enable detailed visualization as well as reduce the time of procedures.
The US constitutes the largest regional market for electrophysiology mapping and ablation devices worldwide, followed distantly by Europe, as stated by the new market research report on Electrophysiology Mapping and Ablation Devices. Increasing focus on treatment of atrial fibrillation through electrophysiological devices represents the primary growth driver for the US market. Moreover, the increasing availability of clinical evidence that proves the curative capability and long term efficacy of catheter ablation is further increasing the acceptance of ablation as a treatment option. As a result, acceptance of this procedure has been on a constant increase. Technological advancements and increase in the unattended Atrial fibrillation patients have also been instrumental in fuelling this growth. Growth for the electrophysiology devices, is however, expected to emanate from Asia-Pacific, which is forecast to increase at a compounded annual growth rate of 11.4% over the analysis period 2009-2017. In terms of individual segments, Electrophysiology Ablation Catheters represent the largest and the fastest growing segment compared to Electrophysiology Mapping Catheters.
Atrial fibrillation entails a large market for mapping and ablation catheters owing to the rising number of patients suffering from the ailment. Aging global population and ineffectiveness of pharmacological treatment have transformed Atrial fibrillation market into an attractive target for device manufacturers worldwide. The fact that catheter ablations, when compared to pharmacotherapy, has lesser side effect, is propelling companies operating in this space to undertake various research activities. Yet, the AF has historically been less penetrated by electrophysiology devices when compared to other medical conditions. Electrophysiology ablation technologies are expected to display strongest performance in the ensuing years in the area of AF treatment. Major factors supporting growth of this technology include its minimally invasive nature, and their ability to cure the diseases as opposed to just managing the symptoms of the condition. Besides, factors such as technological advancements and increasing familiarity of the procedural techniques involved are expected to surge adoption of the treatment in the following years. Employment of robotic navigation technologies along with the ablation procedure would provide additional benefits. Furthermore, advancements in ablation catheter design and remote catheter navigation systems are also expected to provide a thrust to the ablation catheter market. FDA’s approval to conduct arrhythmia through robotic navigation-enabled ablation techniques would further boost the growth in AF ablation market. Catheter ablation devices provide significant potential, as they eliminate cardiac arrhythmias, reduce recovery times, as well as offer long-term solution for atrial fibrillation.
Diagnostic electrophysiology catheters are primarily used for conducting temporary intra-cardiac sensing, recording, simulation and mapping. Demand for the high-priced steerable curve diagnostic EP catheters, would determine the future growth of diagnostic EP catheters. Mapping features in steerable diagnostic EP catheters is also expected to contribute to the growth of the catheter ablation market. Mapping-enabled catheters are expected to dominate the electrophysiology catheters market. Moreover, integration of non-mapping catheters with mapping catheters in the form of 3D model would also provide a boost to the growth of diagnostic catheter ablation market.
Major players profiled in the report include AtriCure Inc., Biosense Webster Inc., Boston Scientific Corp., C.R. Bard Inc., Endosense SA, Hansen Medical Inc., Medtronic Inc., Sichuan Jinjiang Electronic Science and Technology Co. Ltd., St. Jude Medical Inc., Stereotaxis, among others.
The research report titled “Electrophysiology Mapping and Ablation Devices: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of the electrophysiology mapping and ablation devices markets, current market trends, key growth drivers, recent product approvals, recent industry activity, and profiles of major/niche global as well as regional market participants. The report also discusses the different types of Arrhythmias, and provides a detailed analysis of Atrial Fibrillation. The report provides annual sales estimates and projections for electrophysiology mapping and ablation devices market for the years 2009 through 2017 for the following geographic markets - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. The report analyzes the global as well as regional markets by the following segments - Electrophysiology Mapping Catheters, and Electrophysiology Ablation Catheters. Also, a six-year (2003-2008) historic analysis is provided for additional perspective.
For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Electrophysiology_Mapping_and_Ablation_Devices_Market_Report.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/